Stock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors

Stock Track03-18

Shares of Teladoc Health Inc. (TDOC) plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.

Teladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EBITDA guidance fell short of market estimates. Chuck Divita, Chief Executive Officer of Teladoc Health, acknowledged the challenging operating environment, especially for the company's BetterHelp mental health service.

The disappointing results and outlook have taken a toll on Teladoc's stock price, which has fallen by 19.5% since the earnings release. Investors appear to be concerned about the company's ability to stabilize its performance in the face of ongoing market challenges. As the telehealth sector continues to evolve post-pandemic, Teladoc's struggle to maintain growth and meet financial expectations has raised questions about its long-term prospects in the competitive digital healthcare landscape.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1179861070?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-18 23:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179861070","market":"hk","top_or_hot":-1,"title":"Stock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors","media":"Stock Track","content":"<p>Shares of Teladoc Health Inc. (TDOC) plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.</p>\n\n<p>Teladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EBITDA guidance fell short of market estimates. Chuck Divita, Chief Executive Officer of Teladoc Health, acknowledged the challenging operating environment, especially for the company's BetterHelp mental health service.</p>\n\n<p>The disappointing results and outlook have taken a toll on Teladoc's stock price, which has fallen by 19.5% since the earnings release. Investors appear to be concerned about the company's ability to stabilize its performance in the face of ongoing market challenges. As the telehealth sector continues to evolve post-pandemic, Teladoc's struggle to maintain growth and meet financial expectations has raised questions about its long-term prospects in the competitive digital healthcare landscape.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Teladoc Health Plummets 5.02% as Q4 Results and Guidance Disappoint Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-18 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Teladoc Health Inc. (TDOC) plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.</p>\n\n<p>Teladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EBITDA guidance fell short of market estimates. Chuck Divita, Chief Executive Officer of Teladoc Health, acknowledged the challenging operating environment, especially for the company's BetterHelp mental health service.</p>\n\n<p>The disappointing results and outlook have taken a toll on Teladoc's stock price, which has fallen by 19.5% since the earnings release. Investors appear to be concerned about the company's ability to stabilize its performance in the face of ongoing market challenges. As the telehealth sector continues to evolve post-pandemic, Teladoc's struggle to maintain growth and meet financial expectations has raised questions about its long-term prospects in the competitive digital healthcare landscape.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"","article_id":"1179861070","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179861070","pubTimestamp":1742310508,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Teladoc Health Inc.  plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.Teladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EB","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"由于第四季度业绩和指引令投资者失望，Teladoc Health股价暴跌5.02%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Shares of Teladoc Health Inc. (TDOC) plummeted 5.02% in Tuesday's trading session, as investors continued to react negatively to the company's recent fourth-quarter earnings report and disappointing guidance. The telehealth provider has been facing challenges in its business environment, particularly in its mental health segment.\nTeladoc reported Q4 revenues of $640.5 million, representing a 3% year-over-year decline. While this figure was in line with analysts' expectations, the company's full-year EBITDA guidance fell short of market estimates. Chuck Divita, Chief Executive Officer of Teladoc Health, acknowledged the challenging operating environment, especially for the company's BetterHelp mental health service.\nThe disappointing results and outlook have taken a toll on Teladoc's stock price, which has fallen by 19.5% since the earnings release. Investors appear to be concerned about the company's ability to stabilize its performance in the face of ongoing market challenges. As the telehealth sector continues to evolve post-pandemic, Teladoc's struggle to maintain growth and meet financial expectations has raised questions about its long-term prospects in the competitive digital healthcare landscape.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179861070"}